Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xiang Me Lai"'
Autor:
Ruei‐Yu He, Xiang‐Me Lai, Chia‐Sui Sun, Te‐Shien Kung, Jhu‐Ying Hong, Yu‐Song Jheng, Wei‐Neng Liao, Jen‐Kun Chen, Yung‐Feng Liao, Pang‐Hsien Tu, Joseph Jen‐Tse Huang
Publikováno v:
Advanced Science, Vol 7, Iss 2, Pp n/a-n/a (2020)
Abstract Finding an effective therapeutic regimen is an urgent demand for various neurodegenerative disorders including Huntington's disease (HD). For the difficulties in observing the dynamic aggregation and oligomerization process of mutant Hunting
Externí odkaz:
https://doaj.org/article/ea4bbab767c443acb71235cffdefc1b7
Autor:
Mei-Jen Chuang, Sheng-Tang Wu, Shou-Hung Tang, Xiang-Me Lai, Hsiao-Chu Lai, Kai-Hsiang Hsu, Kuang-Hui Sun, Guang-Huan Sun, Sun-Yran Chang, Dah-Shyong Yu, Pei-Wen Hsiao, Shih-Ming Huang, Tai-Lung Cha
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e73401 (2013)
Histone deacetylase inhibitors (HDACIs) have potent anti-cancer activity in a variety of cancer models. Understanding the molecular mechanisms involved in the therapeutic responsiveness of HDACI is needed before its clinical application. This study a
Externí odkaz:
https://doaj.org/article/9096e7b26fb74e678d8a72e8ebaa38cb
Autor:
Yi-Ta Tsai, Sun-Yran Chang, Shih-Ming Huang, Shu-Yu Liu, Xiang-Me Lai, Tai Lung Cha, Guang-Huan Sun
Publikováno v:
Oncotarget
// Xiang-Me Lai 1 , Shu-Yu Liu 2 , Yi-Ta Tsai 3 , Guang-Huan Sun 2 , Sun-Yran Chang 2, 4 , Shih-Ming Huang 1, 3, 5 and Tai-Lung Cha 1, 2, 3, 5 1 Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, R.O.C 2 Division of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63e88ecc0a4e9990d0b410395cce49ea
https://doi.org/10.18632/oncotarget.17923
https://doi.org/10.18632/oncotarget.17923
Autor:
Yung‐Feng Liao, Te‐Shien Kung, Yu‐Song Jheng, Pang-Hsien Tu, Chia-Sui Sun, Wei‐Neng Liao, Ruei-Yu He, Jen‐Kun Chen, Joseph Jen-Tse Huang, Jhu‐Ying Hong, Xiang-Me Lai
Publikováno v:
Advanced Science, Vol 7, Iss 2, Pp n/a-n/a (2020)
Advanced Science
Advanced Science
Finding an effective therapeutic regimen is an urgent demand for various neurodegenerative disorders including Huntington's disease (HD). For the difficulties in observing the dynamic aggregation and oligomerization process of mutant Huntingtin (mHtt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0c7641f209762b60986b81669b06378
https://doi.org/10.1002/advs.201901165
https://doi.org/10.1002/advs.201901165
Autor:
Kuang Hui Sun, Sun Yran Chang, Pei-Wen Hsiao, Guang Huan Sun, Xiang Me Lai, Kai Hsiang Hsu, Hsiao Chu Lai, Dah Shyong Yu, Shih-Ming Huang, Tai-Lung Cha, Sheng Tang Wu, Shou Hung Tang, Mei Jen Chuang
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 9, p e73401 (2013)
PLoS ONE, Vol 8, Iss 9, p e73401 (2013)
Histone deacetylase inhibitors (HDACIs) have potent anti-cancer activity in a variety of cancer models. Understanding the molecular mechanisms involved in the therapeutic responsiveness of HDACI is needed before its clinical application. This study a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cee44eae69204b653ea64304c113f097
http://europepmc.org/articles/PMC3762759
http://europepmc.org/articles/PMC3762759
Autor:
Sang-Hue Yen, Yee Chao, Xiang-Me Lai, Chung-Pin Li, Full-Young Chang, Shou-Dong Lee, Keng-Hsin Lan, Wei-Ping Lee, Jiun-Ming Su
Publikováno v:
Hepatology (Baltimore, Md.). 46(2)
The X protein of hepatitis B virus (HBx) is essential for transactivation of hepatitis B viral and host cellular genes. It has been specifically implicated in the development of hepatocellular carcinoma; however, the molecular mechanism remains unkno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::377bc0a061a81a6838589ce60dad7993
https://pubmed.ncbi.nlm.nih.gov/17559154
https://pubmed.ncbi.nlm.nih.gov/17559154